Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 783 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 226-250 of 778 matching filings.

Per page
25
Current page
10
8-K File 001-36694

CURRENT REPORT

Filing date
03 Nov 2022
Reporting date
03 Nov 2022
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2022
Reporting date
14 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Aug 2022
Reporting date
11 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
09 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
09 Aug 2022
Reporting date
09 Aug 2022
Next action
Verify source filing
4

OWENER SHIP DOCUMENT

Filing date
19 Jul 2022
Reporting date
15 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jul 2022
Reporting date
16 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jul 2022
Reporting date
16 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
18 Jul 2022
Reporting date
16 Jul 2022
Next action
Verify source filing
4

4 filing

Filing date
05 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
21 Jun 2022
Reporting date
20 Jun 2022
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
09 Jun 2022
Reporting date
08 Jun 2022
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
05 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
05 May 2022
Reporting date
05 May 2022
Next action
Verify source filing
DEFA14A File 001-36694

DEFINITIVE ADDITIONAL MATERIALS

Filing date
27 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36694

DEFINITIVE PROXY STATEMENT

Filing date
27 Apr 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .